Lv2
178 积分 2024-01-09 加入
SGLT2 Inhibition and Uric Acid Excretion in Patients with Type 2 Diabetes and Normal Kidney Function
16小时前
已完结
Copanlisib plus rituximab versus placebo plus rituximab in patients with relapsed indolent non-Hodgkin lymphoma (CHRONOS-3): a double-blind, randomised, placebo-controlled, phase 3 trial
6个月前
已完结
Clinical pharmacology and PK/PD translation of the second-generation Bruton’s tyrosine kinase inhibitor, zanubrutinib
6个月前
已完结
Use of the ratio of time to progression following first- and second-line therapy to document the activity of the combination of oxaliplatin with 5-fluorouracil in the treatment of colorectal carcinoma
6个月前
已完结
Assessment of tumour-agnostic therapies in basket trials
6个月前
已完结
Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma
6个月前
已完结
Towards a chemotherapy-free approach in indolent lymphoma
6个月前
已完结
First-line treatment with R-CHOP or rituximab-bendamustine in patients with follicular lymphoma grade 3A—results of a retrospective analysis
6个月前
已完结
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial
6个月前
已完结
Effect of CD40/CD40L signaling on IL-10-producing regulatory B cells in Chinese children with Henoch-Schönlein purpura nephritis
6个月前
已完结
皖公网安备34019202002308
